drug

antihemophilic factor (recombinant), pegylated LA

Marketedupdated 4mo ago

by Baxalta Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying antihemophilic factor (recombinant), pegylated LA

—A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia Aactive not recruitingn=207
phase3A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia Acompletedn=37
—ADYNOVATE Drug Use-Results Surveycompletedn=135
—Post Marketing Surveillance Study for ADYNOVATE in South Koreacompletedn=341

News(1)

After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’
With the post-IPO quiet period having come to an end, CEO Benny Sørensen, M.D., Ph.D., was free to sit down with Fierce to map out Hemab’s future.
fiercebiotech · 1mo ago

Data sources

ClinicalTrials.gov

last refreshed 3h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

antihemophilic factor (recombinant), pegylated LA

Marketedupdated 4mo ago

by Baxalta Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying antihemophilic factor (recombinant), pegylated LA

—A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia Aactive not recruitingn=207
phase3A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia Acompletedn=37
—ADYNOVATE Drug Use-Results Surveycompletedn=135
—Post Marketing Surveillance Study for ADYNOVATE in South Koreacompletedn=341

News(1)

After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’
With the post-IPO quiet period having come to an end, CEO Benny Sørensen, M.D., Ph.D., was free to sit down with Fierce to map out Hemab’s future.
fiercebiotech · 1mo ago

Data sources

ClinicalTrials.gov

last refreshed 3h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

antihemophilic factor (recombinant), pegylated LA

all catalysts(0)

Trials studying antihemophilic factor (recombinant), pegylated LA

News(1)

Report a data issue

comments(0)

antihemophilic factor (recombinant), pegylated LA

all catalysts(0)

Trials studying antihemophilic factor (recombinant), pegylated LA

News(1)

Report a data issue

comments(0)